Accueil › Cancer (tous types) › Washington › Seattle
Essais cliniques pour Cancer (tous types) à Seattle, WA
49 études pour Cancer (tous types) recherchent des participants dans et autour de Seattle (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Recrutement en coursPhase 2/3
- Fred Hutchinson Cancer Center. /ID# 277939, Seattle
Registry Study for Radiation Therapy Outcomes
Recrutement en coursÉtude observationnelle
- University of Washington, Seattle
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Recrutement en coursÉtude observationnelle
- Fred Hutchinson Cancer Center, Seattle
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Recrutement en coursPhase 2/3
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Recrutement en coursPhase 1
- Swedish Cancer Institute, Seattle
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
Recrutement en cours
- Seattle Children's Hospital, Seattle
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
Recrutement en coursPhase 3
- Fred Hutchinson Cancer Center ( Site 0106), Seattle
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Recrutement en coursPhase 2
- Swedish Cancer Institute, Seattle
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Recrutement en coursPhase 2/3
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
Collection of Tissue Samples for Cancer Research
Recrutement en coursÉtude observationnelle
- Fred Hutchinson, Seattle
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Recrutement en coursPhase 2
- Seattle Neuropsychiatric Treatment Center, Seattle
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Recrutement en coursPhase 1
- Investigational Site Number: 400, Seattle
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Recrutement en coursPhase 1
- Fred Hutchinson Cancer Center, Seattle
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Recrutement en coursPhase 3
- Swedish Medical Center, Seattle
- VA Puget Sound Health Care System, Seattle
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Recrutement en coursÉtude observationnelle
- University of Washington, Seattle
Prostate Active Surveillance Study
Recrutement en coursÉtude observationnelle
- Veterans Affairs Puget Sound Health Care System, Seattle
- University of Washington, Seattle
Project: Every Child for Younger Patients With Cancer
Recrutement en coursÉtude observationnelle
- Seattle Children's Hospital, Seattle
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Recrutement en coursPhase 1/2
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
Recrutement en coursVolontaires sains bienvenus
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Recrutement en coursPhase 1
- Fred Hutchinson Cancer Center, Seattle
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Recrutement en coursPhase 2
- Seattle Children's Hospital Research Foundation, Seattle
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Recrutement en coursPhase 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- et 4 autres
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Recrutement en coursPhase 2
- Seattle Children's Hospital, Seattle
Resilience Mobile App for Teens and Young Adults With Cancer
Recrutement en cours
- Seattle Children's Hospital, Seattle
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Recrutement en coursPhase 1
- Fred Hutchinson Cancer Center. /ID# 267940, Seattle
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Recrutement en coursPhase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
Recrutement en coursPhase 1
- GSK Investigational Site, Seattle
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
Childhood Cancer Survivor Study
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Seattle Children's Hospital, Seattle
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Recrutement en cours
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Recrutement en coursPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Recrutement en coursPhase 2/3
- University of Washington Medical Center /ID# 275866, Seattle
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Recrutement en coursPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Recrutement en coursPhase 1/2
- University of Washington Medical Center, Seattle
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
Recrutement en coursPhase 2Volontaires sains bienvenus
- Fred Hutchinson Cancer Centre, Seattle
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Recrutement en coursPhase 2
- University of Washington, Seattle
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
Recrutement en coursPhase 1
- Fred Hutchinson Cancer Center, Seattle
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Recrutement en coursPhase 2
- Seattle Children's Hospital, Seattle
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Recrutement en coursÉtude observationnelle
- Seattle Children's Hospital, Seattle
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Recrutement en coursPhase 2
- Swedish Cancer Institute, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Seattle
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Recrutement en coursPhase 1
- Fred Hutch Cancer Center, Seattle
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Recrutement en coursÉtude observationnelle
- The Swedish Hospital, Seattle
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Recrutement en coursPhase 1/2
- Fred Hutch Cancer Center, Seattle
A Study of NX-1607 in Adults With Advanced Malignancies
Recrutement en coursPhase 1
- Fred Hutchinson Cancer Center, Seattle
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Recrutement en coursÉtude observationnelle
- Swedish Cancer Institute, Seattle
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Recrutement en coursÉtude observationnelle
- University of Washington / Fred Hutchinson Cancer Center, Seattle
A Crowd Sourcing Platform for Patients With Cancer
Recrutement en coursÉtude observationnelle
- All4Cure, Seattle
AIMS Cancer Outcomes Study
Recrutement en coursÉtude observationnelle
- AIMS Institute, Seattle
Essais pour Cancer (tous types) dans d'autres villes
- Houston, TX121 études
- New York City, NY110 études
- Boston, MA86 études
- Los Angeles, CA73 études
- Nashville, TN65 études
- Philadelphia, PA59 études
- Durham, NC58 études
- Washington, DC58 études
- Chicago, IL51 études
- Atlanta, GA49 études
- Arlington, VA48 études
- St. Louis, MO46 études
Autres études à Seattle
- Cancer du poumon non à petites cellules53 études
- Cancer de la prostate42 études
- Leucémie aiguë myéloïde40 études
- Cancer du sein39 études
- Cancer métastatique39 études
- Cancer colorectal34 études
- Cancer du poumon33 études
- Cancer de l'ovaire30 études
- Myélome multiple22 études
- Syndromes myélodysplasiques21 études
- Leucémie aiguë lymphoblastique21 études
- Cancer de la vessie21 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.